Literature DB >> 20334731

Human papillomavirus vaccination and social inequality: results from a prospective cohort study.

S A Roberts1, L Brabin, R Stretch, D Baxter, P Elton, H Kitchener, R McCann.   

Abstract

We investigated the effect of social inequalities on the uptake of human papillomavirus (HPV) vaccination, combining data from a feasibility study conducted in 2007-2008 in 2817 secondary schoolgirls in two UK primary-care trusts, with census and child health records. Uptake was significantly lower in more deprived areas (P<0·001) and in ethnic minority girls (P=0·013). The relatively small proportion of parents who actively refused vaccination by returning a negative consent form were more likely to come from more advantaged areas (P<0·001). Non-responding parents were from more deprived (P<0·001) and ethnic minority (P=0·001) backgrounds. Girls who did not receive HPV vaccination were less likely to have received all their childhood immunizations particularly measles, mumps and rubella (MMR). Different approaches may be needed to maximize HPV vaccine uptake in engaged and non-responding parents, including ethnic-specific approaches for non-responders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20334731     DOI: 10.1017/S095026881000066X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  Vaccine attitudes among young adults in Asia: a systematic review.

Authors:  Li Wang; Yuanyuan Liang; Xuan Zhang; Jinxia Yang
Journal:  Hum Vaccin Immunother       Date:  2020-10-15       Impact factor: 3.452

2.  Human papillomavirus vaccine uptake, knowledge and attitude among 10th grade students in Berlin, Germany, 2010.

Authors:  Petra Stöcker; Manuel Dehnert; Melanie Schuster; Ole Wichmann; Yvonne Deleré
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

3.  High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey.

Authors:  Clare Tanton; Kate Soldan; Simon Beddows; Catherine H Mercer; Jo Waller; Nigel Field; Soazig Clifton; Andrew J Copas; Kavita Panwar; Precious Manyenga; Filomeno da Silva; Kaye Wellings; Catherine A Ison; Anne M Johnson; Pam Sonnenberg
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-03-03       Impact factor: 4.254

4.  Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse.

Authors:  Tammy Boyce; Alison Holmes
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

5.  Explaining variation in the uptake of HPV vaccination in England.

Authors:  Varun M Kumar; David K Whynes
Journal:  BMC Public Health       Date:  2011-03-22       Impact factor: 3.295

6.  HPV vaccination among ethnic minorities in the UK: knowledge, acceptability and attitudes.

Authors:  L A V Marlow
Journal:  Br J Cancer       Date:  2011-08-09       Impact factor: 7.640

7.  Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model.

Authors:  Eva Lefevere; Niel Hens; Frank De Smet; Pierre Van Damme
Journal:  BMC Public Health       Date:  2011-06-14       Impact factor: 3.295

8.  Financial incentives for increasing uptake of HPV vaccinations: a randomized controlled trial.

Authors:  Eleni Mantzari; Florian Vogt; Theresa M Marteau
Journal:  Health Psychol       Date:  2014-08-18       Impact factor: 4.267

Review 9.  Inequalities in the uptake of human papillomavirus vaccination: a systematic review and meta-analysis.

Authors:  Harriet Fisher; Caroline L Trotter; Suzanne Audrey; Kyle MacDonald-Wallis; Matthew Hickman
Journal:  Int J Epidemiol       Date:  2013-04-25       Impact factor: 7.196

Review 10.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.